Additional Risk minimisation materials to minimise potential risk associated with the use of medicines. The materials have been assessed and approved by the national competent authority in line with their Marketing Authorisation.

Cyprus

Czech republic

Denmark

Luxembourg
-

Malta

Netherlands

Romania

Slovakia

Slovenia

Spain

Sweden

United Kingdom